EUCOPE Resources / News - January 31, 2023
Sounds of Science – Episode 12 The new EU HTA Procedure: Getting it right to improve patients’ access to innovative therapies With the entry into force of the EU HTA Regulation in January 2022, the European Commission and EUnetHTA21, a consortium of Member States HTA… read more
News - January 25, 2023
On 25 January 2023, EUCOPE joined an industry coalition calling for better alignment of the Data Act with the GDPR Draft opinion by LIBE Committee as it risks curbing the benefits for innovation and is at odds with the Data Act’s objective to empower users…. read more
Member Spotlight / News - January 25, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In January, we spoke with Jameel Nazir, Vice President Patient Access and Community Engagement at Sobi – Swedish Orphan… read more
News - January 23, 2023
As previously outlined in the EPSCO Council (Health) meeting on 9 December 2022 (Information Note), the European Commission adopted draft legislation on 6 January 2023 amending Regulations (EU) 2017/745 (Medical Devices Regulation – MDR) and (EU) 2017/746 (In Vitro Diagnostics Regulation – IVDR) as regards the transitional… read more
News / Press Releases - January 3, 2023
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new Associate members on 1 January 2023. The new members joining EUCOPE network are: APCO Worldwide, RareLab and SKC. During the announcement, EUCOPE’s Secretary General Alexander Natz said, “The new year means… read more
EUCOPE Resources / News - December 21, 2022
Sounds of Science – Episode 11 2022 Year in Review: Our Policy team’s perspectives on the past year in EU Health and a look ahead to 2023 Throughout 2022, there have been successes, challenges, delays and change within the European pharmaceutical industry and we expect… read more
News - December 16, 2022
Sounds of Science Podcast – Episode 10 Launch Conditionality: The impact on small and mid-sized companies Within the European Commission’s ongoing review of the General Pharmaceutical Legislation and Orphan Medicinal Products (OMP) Regulation, there are several potentially controversial policy options that aim to enhance access… read more
News / Partnerships / Press Releases - December 8, 2022
A new initiative to boost research and development into rare and paediatric diseases will launch today [Thursday 8 December] at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to break down the barriers to finding new treatments and cures… read more
Member Spotlight / News - November 30, 2022
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Óscar Perez, Chief Officer, Marketing, Pricing & Market Access and Business Development at Ferrer Internacional…. read more
News - November 26, 2022
Art. 28 para. 5 HCR is no longer applicable due to an unlawful act of suspension by the European Commission The former president judge at the German Constitutional Court Professor Dr. Udo Di Fabio stated in a legal opinion that the suspension in the assessment… read more
